New Delhi: The Delhi High Court has refused to restrain Sun Pharmaceutical Industries and its wholly-owned subsidiary Sun Pharma Laboratories from selling Pruease tablets , used for constipation relief, on a petition by RSPL Health , which sells sanitary napkins and related products under allegedly similar trademark 'Pro-ease.' RSPL in its trademark infringement petition had alleged that Sun Pharma was using the 'Pruease' name which is deceptively similar to its trademark 'Pro-ease' and the same

New Delhi: Serum Institute of India (SII), and the Drugs for Neglected Diseases initiative ( DNDi ) have signed a Memorandum of Understanding (MOU) to accelerate the clinical development of a monoclonal antibody treatment for dengue. Under the collaboration, DNDi will act as the lead partner for the Phase III clinical trials including leadership, sponsorship, and implementation in Brazil and potentially other endemic countries in Southeast Asia and the Indian vaccine maker will provide the devel

- Engaged with FDA Commissioner on shared commitment to fast, safe, and affordable patient access to innovative therapies SAN DIEGO, June 13, 2025 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox™ platform-based photoimmunotherapy, today announced that it was selected by the U.S. Food and Drug Administration (FDA) to participate in the FDA CEO Forum in San Diego, California, on June 13, 2025. Minami Maeda, President of Rakuten Medica

Jason Menzo Urges Robust FY2026 Funding for National Eye Institute and Protection of Its Independent Status COLUMBIA, Md., June 13, 2025 /PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, today submitted written testimony to the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies through its chief executive officer, Jason Menzo, who served as an expe

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today held its Annual Meeting of Stockholders (the “Annual Meeting”) in a virtual-only format. Preliminary results from the Annual Meeting indicate that two proposals were approved and two proposals were rejected by Vaxart stockholders. Stock

SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases, today announced that on June 10, 2025, the company granted inducement awards to seventeen new employees. The grants were made pur

HERZLIYA, Israel and CALGARY, AB, June 13, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries proudly announces the third party publication of a peer-reviewed narrative review in Cureus journal titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: ). The article discusses the therapeutic potential of long-acting synthetic cannab

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product Device Name Model Number UDI-DI Lot Number IOPS Guidewire ATW-2 H01035 00843152102051 2404-2005 What to Do On April 11, Centerline Biomedical sent all affected customers a letter recommending the following actions: Review your inventory to determine if you have any of

BOLOGNA, Italy, June 13, 2025 /PRNewswire/ -- Datalogic, a global leader in the automatic data capture and factory automation markets, is proud to announce the certification of the Memor 17 Healthcare mobile computer with OncoSafety Remote Control®, the advanced oncology workflow solution developed by B. Braun, a global leader in smart infusion therapy and healthcare technology. This integration combines Datalogic's most advanced healthcare-grade mobile computer with B. Braun's OncoSafety Remote

TORONTO--(BUSINESS WIRE)--Breast Cancer Canada proudly celebrates the federal government’s response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care, and the sweeping reforms it recommends to ensure preventive health guidance in Canada is more equitable, expert-informed, and responsive to real-world care. “These systematic changes will save lives,” said Kimberly Carson, CEO of Breast Cancer Canada. “We commend Canada’s Federal Health Minister Marjorie Mich